Author:
Usmani Sharjeel,Agrawal Kanhaiyalal,Esmail Abdulredha,Marafi Fahad,Gnanasegaran Gopinath
Publisher
Springer International Publishing
Reference17 articles.
1. Even-Sapir E, Metser U, Mishani E, et al. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006;47:287–97.
2. Araz M, Aras G, Kucuk ON. The role of 18F-NaF PET/CT in metastatic bone disease. J Bone Oncol. 2015;4:92–7.
3. Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med. 2010;51:1826–9.
4. Löfgren J, Mortensen J, Rasmussen SH, et al. A prospective study comparing 99mTc-hydroxyethylene-diphosphonate planar bone scintigraphy and whole-body SPECT/CT with 18F-fluoride PET/CT and 18F-fluoride PET/MRI for diagnosing bone metastases. J Nucl Med. 2017;58:1778–85.
5. Laverick S, Bounds G, Wong WL. [18F]-Fluoride positron emission tomography for imaging condylar hyperplasia. Br J Oral Maxillofac Surg. 2009;47:196–9.